Advances in the Application of Acetonitrile in Organic Synthesis since 2018
P Zhong, L Zhang, N Luo, J Liu - Catalysts, 2023 - mdpi.com
Acetonitrile is commonly used as an organic solvent and can also be used as an important
intermediate in organic synthesis. Its widespread use has led to the development of new …
intermediate in organic synthesis. Its widespread use has led to the development of new …
Nicotinonitrile as an essential scaffold in medicinal chemistry: an updated review (2015–present)
Many studies have been carried out to find synthetic pathways to nicotinonitriles (3-
cyanopyridines) and their analogs, which has resulted in a substantial amount of knowledge …
cyanopyridines) and their analogs, which has resulted in a substantial amount of knowledge …
[HTML][HTML] Piezo1 initiates platelet hyperreactivity and accelerates thrombosis in hypertension
W Zhao, Z Wei, G Xin, Y Li, J Yuan, Y Ming, C Ji… - Journal of Thrombosis …, 2021 - Elsevier
Background Thrombosis is the pathological basis of cardiovascular and cerebrovascular
diseases, which seriously threaten human life and health. Among them, nearly half of …
diseases, which seriously threaten human life and health. Among them, nearly half of …
Synthesis, properties, and application of the new nanocatalyst of double layer hydroxides in the one-pot multicomponent synthesis of 2-amino-3-cyanopyridine …
S Momeni, R Ghorbani-Vaghei - Scientific Reports, 2023 - nature.com
A new heterogeneous nanocatalyst LDH@ 3-chloropyltrimethoxysilane@ 1, 3-
benzenedisulfonyl amine@ Cu (LDH@ TRMS@ BDSA@ Cu) was synthesized and …
benzenedisulfonyl amine@ Cu (LDH@ TRMS@ BDSA@ Cu) was synthesized and …
Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis
MMF Ismail, TZ Shawer, RS Ibrahim, RM Allam… - Bioorganic …, 2023 - Elsevier
Vascular endothelial growth factor receptor-2 is a dynamic target for therapeutic intervention
in various types of cancer. This study was aimed at exploring the VEGFR-2 inhibitory activity …
in various types of cancer. This study was aimed at exploring the VEGFR-2 inhibitory activity …
Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study
For the horseshoe tactic to succeed in inhibiting c-Met and Pim-1, the nicotinonitrile
derivatives (2a-n) were produced in high quantities by coupling acetyl phenylpyrazole (1) …
derivatives (2a-n) were produced in high quantities by coupling acetyl phenylpyrazole (1) …
Novel azo pyridone dyes based on dihydropyrimidinone skeleton: Synthesis, DFT study and anticancer activity
JD Tadić, JM Lađarević, ŽJ Vitnik, VD Vitnik… - Dyes and …, 2021 - Elsevier
Seven novel azo dyes with 2-pyridone and dihydropyrimidinone moieties have been
synthesized and thoroughly characterized. The azo-hydrazone tautomerism has been …
synthesized and thoroughly characterized. The azo-hydrazone tautomerism has been …
Aminopyridone-linked benzimidazoles: a fragment-based drug design for the development of CDK9 inhibitors
EM Husseiny, HS Abulkhair, SSA El-Hddad… - Future Medicinal …, 2023 - Taylor & Francis
Aim: A fragment-based design and synthesis of three novel series of aminopyridone-linked
benzimidazoles as potential anticancer candidates with significant CDK9 inhibition was …
benzimidazoles as potential anticancer candidates with significant CDK9 inhibition was …
Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition
SM Aboukhatwa, AO Ibrahim, H Aoyama… - Bioorganic …, 2022 - Elsevier
Although a plethora of targeted anticancer small molecule drugs became available, the low
response rate and drug resistance imply the continuous need for expanding the anticancer …
response rate and drug resistance imply the continuous need for expanding the anticancer …
Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors
AKA Bass, ESM Nageeb, MS El-Zoghbi… - Bioorganic …, 2022 - Elsevier
Herein, we report design and synthesis of twenty-one dual PIM-1/HDAC inhibitors utilizing 3-
cyanopyridines as a novel cap moiety linked with aliphatic/aromatic linker bearing carboxylic …
cyanopyridines as a novel cap moiety linked with aliphatic/aromatic linker bearing carboxylic …